Leader in Cancer Research
The Duke Cancer Institute is a leader in clinical, basic, translational, and population research. Learn more about us.
Disease-Site Groups
The Duke Cancer Institute comprises 10 Disease-Site Groups with a trio of leaders representing clinical care, clinical research, and basic research, working together to promote and advance the diagnosis, treatment, and continuing care of patients.
NCI-Designated Programs
The Duke Cancer Institute has nine basic, clinical, and translational NCI-Designated Programs that are designed to address research opportunities impacting cancer care.
